REMSleep Holdings, Inc. (RMSL)
USD 0.01
(-6.25%)
USD 0.01
(-6.25%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.77 Million USD | -17.13% |
| 2022 | -1.51 Million USD | 68.01% |
| 2021 | -4.74 Million USD | -165.49% |
| 2020 | -1.78 Million USD | 58.3% |
| 2019 | -4.28 Million USD | -938.32% |
| 2018 | -412.7 Thousand USD | 36.89% |
| 2017 | -653.96 Thousand USD | -231.81% |
| 2016 | -197.09 Thousand USD | -128.19% |
| 2015 | -86.37 Thousand USD | 80.87% |
| 2014 | -451.49 Thousand USD | 83.65% |
| 2013 | -2.76 Million USD | 84.23% |
| 2012 | -17.5 Million USD | 7.93% |
| 2011 | -19.01 Million USD | 83.24% |
| 2010 | -113.42 Million USD | -475788.63% |
| 2009 | -23.83 Thousand USD | 27.94% |
| 2008 | -33.07 Thousand USD | 12.49% |
| 2007 | -37.79 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -252.58 Thousand USD | 76.13% |
| 2024 Q2 | -225.59 Thousand USD | 10.68% |
| 2023 Q3 | -270.43 Thousand USD | -21.16% |
| 2023 FY | -1.77 Million USD | -17.13% |
| 2023 Q4 | -1.05 Million USD | -291.21% |
| 2023 Q1 | -236.82 Thousand USD | 44.08% |
| 2023 Q2 | -223.19 Thousand USD | 5.75% |
| 2022 Q1 | -304.39 Thousand USD | -92.22% |
| 2022 FY | -1.51 Million USD | 68.01% |
| 2022 Q4 | -423.47 Thousand USD | -33.25% |
| 2022 Q3 | -317.81 Thousand USD | 34.27% |
| 2022 Q2 | -483.51 Thousand USD | -58.84% |
| 2021 Q1 | -471.46 Thousand USD | 29.56% |
| 2021 Q3 | -832.15 Thousand USD | 64.79% |
| 2021 Q4 | -158.35 Thousand USD | 80.97% |
| 2021 FY | -4.74 Million USD | -165.49% |
| 2021 Q2 | -2.36 Million USD | -401.35% |
| 2020 FY | -1.78 Million USD | 58.3% |
| 2020 Q1 | -273.52 Thousand USD | 68.66% |
| 2020 Q2 | 38.83 Thousand USD | 114.2% |
| 2020 Q3 | -271.47 Thousand USD | -799.08% |
| 2020 Q4 | -669.28 Thousand USD | -146.54% |
| 2019 FY | -4.28 Million USD | -938.32% |
| 2019 Q4 | -872.83 Thousand USD | -1031.37% |
| 2019 Q3 | -77.14 Thousand USD | 96.71% |
| 2019 Q1 | -591.73 Thousand USD | -245.76% |
| 2019 Q2 | -2.34 Million USD | -296.59% |
| 2018 Q3 | -348.91 Thousand USD | -13.43% |
| 2018 Q2 | -307.61 Thousand USD | -89.74% |
| 2018 Q1 | -162.12 Thousand USD | 64.17% |
| 2018 FY | -412.7 Thousand USD | 36.89% |
| 2018 Q4 | 405.95 Thousand USD | 216.35% |
| 2017 Q4 | -452.5 Thousand USD | -844.63% |
| 2017 Q3 | -47.9 Thousand USD | 87.69% |
| 2017 Q2 | -389.06 Thousand USD | 6.17% |
| 2017 Q1 | -414.66 Thousand USD | -147.85% |
| 2017 FY | -653.96 Thousand USD | -231.81% |
| 2016 Q4 | -167.3 Thousand USD | -69321.16% |
| 2016 Q1 | -26.26 Thousand USD | -96.45% |
| 2016 Q2 | -3230.00 USD | 87.7% |
| 2016 Q3 | -241.00 USD | 92.54% |
| 2016 FY | -197.09 Thousand USD | -128.19% |
| 2015 Q1 | -34.16 Thousand USD | -8432.44% |
| 2015 FY | -86.37 Thousand USD | 80.87% |
| 2015 Q4 | -13.36 Thousand USD | -5711.74% |
| 2015 Q3 | -230.00 USD | 99.4% |
| 2015 Q2 | -38.61 Thousand USD | -13.03% |
| 2014 FY | -451.49 Thousand USD | 83.65% |
| 2014 Q4 | 410.00 USD | 102.13% |
| 2014 Q3 | -19.26 Thousand USD | -111.23% |
| 2014 Q2 | 171.52 Thousand USD | 119.93% |
| 2014 Q1 | -860.66 Thousand USD | 59.75% |
| 2013 FY | -2.76 Million USD | 84.23% |
| 2013 Q1 | -206.28 Thousand USD | 83.42% |
| 2013 Q2 | -1.91 Million USD | -829.19% |
| 2013 Q3 | -517.83 Thousand USD | 72.98% |
| 2013 Q4 | -2.13 Million USD | -312.88% |
| 2012 Q4 | -1.24 Million USD | -2173.43% |
| 2012 FY | -17.5 Million USD | 7.93% |
| 2012 Q1 | -17.25 Thousand USD | 99.91% |
| 2012 Q2 | -16.14 Million USD | -93472.66% |
| 2012 Q3 | -54.72 Thousand USD | 99.66% |
| 2011 FY | -19.01 Million USD | 83.24% |
| 2011 Q3 | - USD | 100.0% |
| 2011 Q2 | -69.18 Thousand USD | -262.98% |
| 2011 Q1 | -19.06 Thousand USD | 89.63% |
| 2011 Q4 | -18.92 Million USD | 0.0% |
| 2010 Q4 | -183.79 Thousand USD | 44.57% |
| 2010 Q3 | -331.56 Thousand USD | -55.88% |
| 2010 Q2 | -212.69 Thousand USD | -6599.18% |
| 2010 Q1 | -3175.00 USD | -638.14% |
| 2010 FY | -113.42 Million USD | -475788.63% |
| 2009 Q1 | -12.9 Thousand USD | -282.98% |
| 2009 Q2 | -11.32 Thousand USD | 12.21% |
| 2009 Q4 | 590.00 USD | 395.0% |
| 2009 Q3 | -200.00 USD | 98.23% |
| 2009 FY | -23.83 Thousand USD | 27.94% |
| 2008 Q1 | -6500.00 USD | 16.63% |
| 2008 Q4 | 7050.00 USD | 217.5% |
| 2008 Q3 | -6000.00 USD | 77.46% |
| 2008 FY | -33.07 Thousand USD | 12.49% |
| 2008 Q2 | -26.62 Thousand USD | -309.62% |
| 2007 Q3 | -275.00 USD | 0.0% |
| 2007 Q4 | -7797.00 USD | -2735.27% |
| 2007 FY | -37.79 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | -145.961% |
| IR-Med Inc. | -4.9 Million USD | 63.784% |
| Polarean Imaging plc | -11.88 Million USD | 85.041% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 550.268% |
| Avitar, Inc. | -2.25 Million USD | 21.322% |
| AVITA Medical, Inc. | -39.16 Million USD | 95.461% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -52.604% |
| Össur hf. | 58.38 Million USD | 103.045% |
| Zecotek Photonics Inc. | -3.51 Million USD | 49.479% |
| QHSLab, Inc. | -468.36 Thousand USD | -279.586% |
| Wellstar International, Inc. | -3.1 Million USD | 42.807% |
| Össur hf. | 58.38 Million USD | 103.045% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 175.588% |
| Escalon Medical Corp. | -125.26 Thousand USD | -1319.307% |
| Aurora Spine Corporation | -1.68 Million USD | -5.788% |
| BrainsWay Ltd. | -4.19 Million USD | 57.64% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -11.49 Million USD | 84.536% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | -192.879% |
| Vivos Inc. | -2.89 Million USD | 38.584% |
| MicroPort Scientific Corporation | -477.62 Million USD | 99.628% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | -713.764% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | -325.287% |
| Nanomix Corporation | -12.33 Million USD | 85.585% |
| Theraclion SA | -3.67 Million USD | 51.624% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | -136.107% |
| Positron Corporation | -1.63 Million USD | -8.491% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 32.689% |
| Lombard Medical, Inc. | -31.03 Million USD | 94.272% |
| ALR Technologies Inc. | -11.89 Million USD | 85.056% |
| Stratec SE | 14.42 Million USD | 112.324% |
| Vycor Medical, Inc. | -69.69 Thousand USD | -2451.03% |
| Heart Tronics, Inc. | -13.32 Million USD | 86.66% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | -1316.311% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 87.334% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 93.111% |
| VMS Rehab Systems, Inc. | 46.44 USD | 3828347.201% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 49.044% |
| Ingen Technologies, Inc. | -5.06 Million USD | 64.875% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | -96.279% |
| United American Healthcare Corporation | 723 Thousand USD | 345.897% |
| ECGI Holdings, Inc. | -3.61 Million USD | 50.765% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | -170.178% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | -148.007% |
| Urologix, Inc. | -7.6 Million USD | 76.632% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | -4.961% |
| Nexeon MedSystems Inc. | -2.17 Million USD | 18.359% |
| SS Innovations International, Inc. | -20.94 Million USD | 91.511% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | -120.844% |
| Smith & Nephew plc | 263 Million USD | 100.676% |
| NIOX Group Plc | 13.64 Million USD | 113.034% |
| Fuse Medical, Inc. | 1.45 Million USD | 221.773% |
| Broncus Holding Corporation | -28.09 Million USD | 93.671% |
| Brain Scientific Inc. | -12.34 Million USD | 85.597% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 93.935% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | -1009.429% |